ZA913362B - Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis - Google Patents

Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis

Info

Publication number
ZA913362B
ZA913362B ZA913362A ZA913362A ZA913362B ZA 913362 B ZA913362 B ZA 913362B ZA 913362 A ZA913362 A ZA 913362A ZA 913362 A ZA913362 A ZA 913362A ZA 913362 B ZA913362 B ZA 913362B
Authority
ZA
South Africa
Prior art keywords
hydroxyphenylthio
bis
substituted
alkyl
cataractogenesis
Prior art date
Application number
ZA913362A
Other languages
English (en)
Inventor
Simon Jen Tan Mao
Jen Tan Mao Simon
Richard Lee Jackson
Lee Jackson Richard
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA913362B publication Critical patent/ZA913362B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
ZA913362A 1990-05-09 1991-05-03 Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis ZA913362B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/521,293 US5061734A (en) 1990-05-09 1990-05-09 Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis

Publications (1)

Publication Number Publication Date
ZA913362B true ZA913362B (en) 1992-03-25

Family

ID=24076166

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA913362A ZA913362B (en) 1990-05-09 1991-05-03 Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis

Country Status (11)

Country Link
US (1) US5061734A (de)
EP (1) EP0456209B1 (de)
JP (1) JP3040005B2 (de)
KR (1) KR0168648B1 (de)
AT (1) ATE108652T1 (de)
AU (1) AU631738B2 (de)
DE (1) DE69102936T2 (de)
DK (1) DK0456209T3 (de)
ES (1) ES2060239T3 (de)
IE (1) IE64371B1 (de)
ZA (1) ZA913362B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411741A (en) * 1993-07-29 1995-05-02 Zaias; Nardo Method and composition for skin depigmentation
US5665770A (en) * 1993-11-05 1997-09-09 Gakko Hojin Kinki Daigaku Method for treatment of cataract with radical scavenger
US5677291A (en) * 1993-12-10 1997-10-14 Hoechst Marion Roussel, Inc. Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
US5686450A (en) * 1995-06-07 1997-11-11 Alcon Laboratories, Inc. Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents
US5576278A (en) * 1995-06-07 1996-11-19 Alcon Laboratories, Inc. Stable liquid enzyme compositions and methods of use
WO1997026879A1 (en) * 1996-01-26 1997-07-31 The United States Of America, Represented By The Secretary, Department Of Health And Human Services, The National Institutes Of Health Hydroxylamine compositions for the prevention or retardation of cataracts
US5795876A (en) * 1996-04-30 1998-08-18 Hoechst Marion Rousssel, Inc. Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols
US5608095A (en) * 1996-04-30 1997-03-04 Hoechst Marion Roussel, Inc. Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
US6114572A (en) * 1996-11-20 2000-09-05 Hoechst Marion Roussel, Inc. Substituted phenols and thiophenols useful as antioxidant agents
US6670398B2 (en) * 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
IL164568A0 (en) * 1997-05-14 2005-12-18 Atherogenics Inc Compounds and methods for the inhibition of the expression of vcam-1
US6121463A (en) * 1997-06-24 2000-09-19 Hoechst Marion Roussel, Inc. Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents
US6133467A (en) * 1997-06-25 2000-10-17 Hoechst Marion Roussel, Inc. 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol
WO2002087556A2 (en) * 2001-04-11 2002-11-07 Atherogenics, Inc. Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality
WO2008118948A1 (en) * 2007-03-26 2008-10-02 Atherogenics, Inc. Methods and compositions of derivatives of probucol for the treatment of diabetes
WO2008118946A1 (en) * 2007-03-27 2008-10-02 Atherogenics, Inc. Methods and compositions using certain phenolic derivatives for the treatment of diabetes

Also Published As

Publication number Publication date
EP0456209B1 (de) 1994-07-20
KR910019632A (ko) 1991-12-19
DE69102936T2 (de) 1994-12-15
DE69102936D1 (de) 1994-08-25
JPH04226912A (ja) 1992-08-17
AU7527791A (en) 1991-11-14
EP0456209A2 (de) 1991-11-13
IE64371B1 (en) 1995-07-26
US5061734A (en) 1991-10-29
ATE108652T1 (de) 1994-08-15
IE911564A1 (en) 1991-11-20
JP3040005B2 (ja) 2000-05-08
ES2060239T3 (es) 1994-11-16
EP0456209A3 (en) 1992-06-24
DK0456209T3 (da) 1994-09-05
AU631738B2 (en) 1992-12-03
KR0168648B1 (ko) 1999-01-15

Similar Documents

Publication Publication Date Title
ZA913362B (en) Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
DE59109222D1 (de) Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen
TW224942B (de)
DE69525291D1 (de) Bisphosphonat und anti-Resorption Agentien, enthaltende Zusammensetzungen zur Hemmung der Knochenschwund
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
ATE157251T1 (de) Verwendung von inositoltriphosphat zur behandlung von entzündungen
DE69022953D1 (de) Zusammensetzungen zur Behandlung von Fettablagerungen.
SG49228A1 (en) Use of 2-amino-6-A-propyl-amino-4,5,6,7- tetrahydrobenzothiazole(pramipexol) as a antidepressant activity
ES2179996T3 (es) Cefalosporinas de vinil-pirrolidinona con sustituyentes basicos.
ES2180564T3 (es) 2-fenil-3-azoilbenzotiofenos para aumentar la expresion de trombomodulina.
GB2223403B (en) Inositoltrisphosphate for the treatment of disorders related to transplantation
ATE184788T1 (de) Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer
IL111580A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders
EP0305181A3 (en) Ethyl-(+)-apovincaminate for treating demyelinization clinical patterns of autoimmune origin
IL105475A0 (en) Pharmaceutical compositions containing 1alpha,24(r)-dihydroxy-22(e)-dehydro-vitamin d3 for treating osteoporosis
ES8707495A1 (es) Un procedimiento para preparar derivados de azetidinona
ATE140228T1 (de) Hydroxymethyl-indolizidine und -chinolizidine
DK360388D0 (da) Laegemiddel til behandling af hjerteinsufficiens
EP0353910A3 (en) Human interferon-gamma, process for preparing said human interferon-gamma, and its use
ES2072005T3 (es) Utilizacion de analogos de 20(r)-22-oxa-vitamina d en la preparacion de un medicamento para el tratamiento del envejecimiento de la piel.
ES2116522T3 (es) Compuestos citotoxicos.
FR2474863B1 (de)
FR2481697B1 (de)